|
EP0809492A4
(en)
*
|
1995-02-17 |
2007-01-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6054472A
(en)
*
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6211373B1
(en)
*
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
|
US6686353B1
(en)
|
1996-05-20 |
2004-02-03 |
Teijin Intellectual Property Center Limited |
Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
|
|
WO1997049399A1
(en)
*
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
JP2001523220A
(ja)
*
|
1996-08-06 |
2001-11-20 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ―８受容体アンタゴニスト
|
|
JP2000515554A
(ja)
|
1996-08-06 |
2000-11-21 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ―８受容体アンタゴニスト
|
|
JP2000516620A
(ja)
*
|
1996-08-15 |
2000-12-12 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ―８レセプターアンタゴニスト
|
|
WO1998017312A1
(en)
*
|
1996-10-22 |
1998-04-30 |
Chugai Seiyaku Kabushiki Kaisha |
Sepsis remedy comprising anti-il-8 antibody as active ingredient
|
|
DE19651040C2
(de)
*
|
1996-12-09 |
1999-01-28 |
Bayer Ag |
Verfahren zur Herstellung von 2-Amino-5-alkyl-phenolen
|
|
BR9807083A
(pt)
|
1997-01-23 |
2000-04-18 |
Smithkline Beckman Corp |
Antagonistas ao receptor de il-8
|
|
US6436927B1
(en)
|
1997-02-12 |
2002-08-20 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
DE69824837T2
(de)
*
|
1997-02-12 |
2005-08-25 |
Smithkline Beecham Corp. |
Il-8-rezeptor-antagonisten
|
|
US6696475B2
(en)
|
1997-04-22 |
2004-02-24 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
|
US6344476B1
(en)
*
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
|
AU8270898A
(en)
*
|
1997-06-26 |
1999-01-19 |
Eli Lilly And Company |
Antithrombotic agents
|
|
AU8673198A
(en)
*
|
1997-07-29 |
1999-02-22 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
US6989435B2
(en)
|
1997-09-11 |
2006-01-24 |
Cambridge University Technical Services Ltd. |
Compounds and methods to inhibit or augment an inflammatory response
|
|
US7067117B1
(en)
|
1997-09-11 |
2006-06-27 |
Cambridge University Technical Services, Ltd. |
Compounds and methods to inhibit or augment an inflammatory response
|
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
|
HUP0101704A3
(en)
*
|
1997-12-22 |
2002-12-28 |
Bayer Corp Pittsburgh |
Kinease substituted heterocyclic ureas with raf inhibition activity and pharmaceutical compositions containing them
|
|
US20080300281A1
(en)
*
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
|
EP1049664B1
(en)
*
|
1997-12-22 |
2005-03-16 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
|
|
AU2003204708B2
(en)
*
|
1997-12-22 |
2006-05-25 |
Bayer Healthcare Llc |
Inhibition of Raf Kinase using Substituted Heterocyclic Ureas
|
|
EP1087661A4
(en)
*
|
1998-06-17 |
2003-04-16 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
TR200100219T2
(tr)
*
|
1998-07-23 |
2001-06-21 |
Smithkline Beecham Corporation |
IL-8 Reseptörü Antagonistleri
|
|
WO2000012468A1
(en)
*
|
1998-08-28 |
2000-03-09 |
Smithkline Beecham Corporation |
An improved synthesis of 3-hydroxy-4-amino-benzonitrile
|
|
SK5222001A3
(en)
*
|
1998-10-22 |
2002-05-09 |
Neurosearch As |
Substituted phenyl derivatives, their preparation and use
|
|
US6262090B1
(en)
|
1998-12-09 |
2001-07-17 |
American Home Products Corporation |
Aminopyridine-containing thiourea inhibitors of herpes viruses
|
|
US6166028A
(en)
|
1998-12-09 |
2000-12-26 |
American Home Products Corporation |
Diaminopuridine-containing thiourea inhibitors of herpes viruses
|
|
US6255349B1
(en)
|
1998-12-09 |
2001-07-03 |
American Home Products Corporation |
Alph-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
|
|
US6201013B1
(en)
|
1998-12-09 |
2001-03-13 |
American Home Products Corporation |
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
|
|
AU1934600A
(en)
*
|
1998-12-09 |
2000-06-26 |
Wyeth |
Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
|
|
US6335350B1
(en)
|
1998-12-09 |
2002-01-01 |
American Home Products Corporation |
Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
|
|
US6207715B1
(en)
|
1998-12-09 |
2001-03-27 |
American Home Products Corporation |
Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a substituted phenylene-diamine group
|
|
CZ20011957A3
(cs)
*
|
1998-12-09 |
2001-10-17 |
American Home Products Corporation |
Thiomočoviny jako inhibitory herpes virů
|
|
US6197803B1
(en)
|
1998-12-09 |
2001-03-06 |
American Home Products Corporation |
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
|
|
US20080269265A1
(en)
*
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
|
EP1140840B1
(en)
|
1999-01-13 |
2006-03-22 |
Bayer Pharmaceuticals Corp. |
-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US7351834B1
(en)
*
|
1999-01-13 |
2008-04-01 |
Bayer Pharmaceuticals Corporation |
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
CA2359244C
(en)
|
1999-01-13 |
2013-10-08 |
Bayer Healthcare Llc |
.omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
JP2002537397A
(ja)
|
1999-02-22 |
2002-11-05 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症剤としての多環ヘテロ環式誘導体
|
|
HUP0202248A3
(en)
|
1999-03-12 |
2006-06-28 |
Boehringer Ingelheim Pharma |
Compounds useful as anti-inflammatory agents
|
|
EP1163236B1
(en)
*
|
1999-03-12 |
2005-11-09 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
|
RU2284187C2
(ru)
*
|
1999-03-17 |
2006-09-27 |
Астразенека Аб |
Производные амида, способы их получения, фармацевтическая композиция, способ лечения
|
|
AR029361A1
(es)
*
|
1999-05-28 |
2003-06-25 |
Smithkline Beecham Corp |
Compuestos de guanidina ciclicas antagonistas de los receptores de la il- 8, composicion farmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento
|
|
CO5190710A1
(es)
*
|
1999-06-15 |
2002-08-29 |
Smithkline Beecham Corp |
Antagonistas de un receptor de il-8 un receptor de il-8
|
|
CO5200760A1
(es)
*
|
1999-06-16 |
2002-09-27 |
Smithkline Beecham Corp |
Antagonistas del receptor de la il-8 ceptor il-8
|
|
BR0012157A
(pt)
*
|
1999-07-07 |
2002-04-02 |
Astrazeneca Uk Ltd |
Derivado de quinazolina, derivado de pirimidina, processo para a preparação de um derivado de quinazolina, composição farmacêutica, uso de um derivado de quinazolina, e, método para a prevenção ou tratamento de doenças ou condições médicas pela célula t um em animal de sangue quente em necessidade de tal tratamento
|
|
MXPA02000314A
(es)
|
1999-07-09 |
2004-06-22 |
Boehringer Ingelheim Pharma |
Proceso novedoso para la sintesis de compuestos de urea substituidos con heteroarilo.
|
|
AU6314900A
(en)
|
1999-07-26 |
2001-02-13 |
Banyu Pharmaceutical Co., Ltd. |
Biarylurea derivatives
|
|
CO5271663A1
(es)
*
|
1999-11-09 |
2003-04-30 |
Smithkline Beecham Corp |
Antagonistas del receptor il-8
|
|
MXPA02004879A
(es)
|
1999-11-16 |
2002-08-30 |
Boehringer Ingelheim Pharma |
Derivados de urea como agentes antiinflamatorios.
|
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
JP2003524655A
(ja)
*
|
2000-03-01 |
2003-08-19 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ−８受容体アンタゴニスト
|
|
MY133845A
(en)
*
|
2000-03-10 |
2007-11-30 |
Smithkline Beecham Corp |
Il-8 receptor antagonists
|
|
AU2001245605A1
(en)
*
|
2000-03-10 |
2001-09-24 |
Smith Kline Beecham Corporation |
Il-8 receptor antagonists
|
|
JP2003527360A
(ja)
*
|
2000-03-14 |
2003-09-16 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ−８受容体アンタゴニスト
|
|
CO5280089A1
(es)
*
|
2000-03-16 |
2003-05-30 |
Smithkline Beecham Corp |
Antagonistas del receptor il-8
|
|
UY26627A1
(es)
*
|
2000-03-24 |
2001-09-28 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
|
CN1423635A
(zh)
*
|
2000-04-14 |
2003-06-11 |
吴羽化学工业株式会社 |
含氮化合物以及使用该化合物的抗病毒药
|
|
CN1454204A
(zh)
*
|
2000-05-30 |
2003-11-05 |
史密丝克莱恩比彻姆公司 |
Il－8受体拮抗剂
|
|
CZ2003132A3
(cs)
*
|
2000-07-18 |
2003-09-17 |
Smithkline Beecham Corporation |
Farmaceutický prostředek pro léčení příznaků běžného nachlazení
|
|
WO2002022565A1
(en)
*
|
2000-09-15 |
2002-03-21 |
Iconix Pharmaceuticals, Inc. |
Inhibitors of rho c
|
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
WO2002067919A1
(en)
*
|
2001-01-16 |
2002-09-06 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
AR032398A1
(es)
*
|
2001-01-16 |
2003-11-05 |
Smithkline Beecham Corp |
Compuesto de escuaramida de sulfonamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar dicha composicion
|
|
DE10109204A1
(de)
*
|
2001-02-26 |
2002-09-19 |
4Sc Ag |
Verbindungen zur Behandlung von Protozoen-Erkrankungen
|
|
US6949567B2
(en)
|
2001-02-26 |
2005-09-27 |
4Sc Ag |
Compounds for the treatment of protozoal diseases
|
|
ITMI20010395A1
(it)
*
|
2001-02-27 |
2002-08-27 |
Dompe Spa |
Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate
|
|
JP4171656B2
(ja)
|
2001-02-28 |
2008-10-22 |
テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション |
Ｎ−（アリール）−２−アリールエテンスルホンアミド及びその製薬用途
|
|
US7371763B2
(en)
*
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
WO2002094261A1
(fr)
*
|
2001-05-24 |
2002-11-28 |
Kureha Chemical Industry Company, Limited |
Medicaments antagonistes de cxcr4 comprenant un compose contenant de l'azote
|
|
US20040038854A1
(en)
*
|
2001-07-16 |
2004-02-26 |
Dillon Susan B. |
Use of il-8 receptor antagonists in the treatment of virus infections
|
|
US6791892B2
(en)
*
|
2001-07-18 |
2004-09-14 |
Samsung Electronics Co., Ltd. |
Method of generating an initializing signal during power-up of semiconductor memory device
|
|
AU2002351196A1
(en)
*
|
2001-12-03 |
2003-06-17 |
Bayer Pharmaceuticals Corporation |
Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
|
|
US20080108672A1
(en)
*
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
|
US20030216396A1
(en)
*
|
2002-02-11 |
2003-11-20 |
Bayer Corporation |
Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
|
|
SI1580188T1
(sl)
*
|
2002-02-11 |
2012-02-29 |
Bayer Healthcare Llc |
Aril sečnine kot kinazni inhibitorji
|
|
WO2003068223A1
(en)
*
|
2002-02-11 |
2003-08-21 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenesis inhibiting activity
|
|
EP2324825A1
(en)
|
2002-02-11 |
2011-05-25 |
Bayer Healthcare LLC |
Aryl ureas with angiogenesis inhibiting activity
|
|
US7041669B2
(en)
|
2002-02-25 |
2006-05-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-benzofused urea compounds useful in treating cytokine mediated diseases
|
|
US7161031B2
(en)
*
|
2002-02-28 |
2007-01-09 |
Temple University - Of The Commonwealth System Of Higher Education |
Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
|
|
KR20030080509A
(ko)
*
|
2002-04-09 |
2003-10-17 |
주식회사 엘지생명과학 |
우레아, 티오우레아 및 설파마이드 유도체를 함유하는항균제 조성물
|
|
US20030236287A1
(en)
*
|
2002-05-03 |
2003-12-25 |
Piotrowski David W. |
Positive allosteric modulators of the nicotinic acetylcholine receptor
|
|
ATE372770T1
(de)
*
|
2002-08-01 |
2007-09-15 |
Neurosearch As |
Verbindungen nützlich in der behandlung von erkrankungen die auf anti-angiogenertherapie antworten
|
|
AU2003261974A1
(en)
*
|
2002-09-11 |
2004-04-30 |
Kureha Chemical Industry Company, Limited |
Amine compounds and use thereof
|
|
EP1402887A1
(en)
*
|
2002-09-18 |
2004-03-31 |
Jerini AG |
New compounds for the inhibition of undesired cell proliferation and use thereof
|
|
AR041834A1
(es)
|
2002-10-29 |
2005-06-01 |
Smithkline Beecham Corp |
Compuesto de difenilurea sustituido con sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
|
|
DE10251830A1
(de)
*
|
2002-11-07 |
2004-05-19 |
Wella Ag |
2-Amino-5-ethylphenol enthaltendes Mittel zum Färben von Keratinfasern
|
|
CN1714076A
(zh)
*
|
2002-11-21 |
2005-12-28 |
神经研究公司 |
芳基脲基衍生物及其医药用途
|
|
AU2003300360A1
(en)
*
|
2002-12-20 |
2004-07-22 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
|
WO2004058722A1
(en)
*
|
2002-12-24 |
2004-07-15 |
Arena Pharmaceuticals, Inc. |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
|
US7220768B2
(en)
*
|
2003-02-11 |
2007-05-22 |
Wyeth Holdings Corp. |
Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
|
|
AU2004212633B2
(en)
*
|
2003-02-21 |
2010-12-09 |
ResMed Pty Ltd |
Nasal assembly
|
|
UY28213A1
(es)
*
|
2003-02-28 |
2004-09-30 |
Bayer Pharmaceuticals Corp |
Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
|
|
EP1457485A1
(en)
*
|
2003-03-14 |
2004-09-15 |
Dompé S.P.A. |
Sulfonic acids, their derivatives and pharmaceutical compositions containing them
|
|
EP1608319A4
(en)
*
|
2003-04-03 |
2007-02-28 |
Univ California |
IMPROVED HEMMER FOR SOLUBLE EPOXY HYDROLASE
|
|
DE602004007382T2
(de)
|
2003-05-20 |
2008-04-17 |
Bayer Pharmaceuticals Corp., West Haven |
Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
|
|
EP1558582B1
(en)
|
2003-07-22 |
2005-12-21 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
DK1663978T3
(da)
|
2003-07-23 |
2008-04-07 |
Bayer Pharmaceuticals Corp |
Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
|
|
WO2005023238A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Poseidon Pharmaceuticals A/S |
Erg channel openers for the treatment of hyperexcitability-related neuronal diseases
|
|
AU2004269924A1
(en)
|
2003-09-04 |
2005-03-17 |
Neurosearch A/S |
ERG channel openers for the treatment of cardiac arrhythmias
|
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
|
JP3977411B2
(ja)
*
|
2004-03-10 |
2007-09-19 |
株式会社クレハ |
アミン系塩基性化合物とその用途
|
|
JP2007532484A
(ja)
|
2004-03-16 |
2007-11-15 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
可溶性エポキシド加水分解酵素の阻害剤およびエポキシエイコサノイドを用いて腎症を緩和する方法
|
|
CN1926114B
(zh)
*
|
2004-03-23 |
2011-08-24 |
艾尼纳制药公司 |
用于制备经取代n-芳基-n′-′3-(1h-吡唑-5-基)苯基脲及其中间体的方法
|
|
CA2561639A1
(en)
*
|
2004-03-29 |
2005-10-06 |
Neurosearch A/S |
Novel urea derivatives and their medical use
|
|
JP2007535565A
(ja)
|
2004-04-30 |
2007-12-06 |
バイエル ファーマシューティカルス コーポレーション |
癌の治療に有用な置換ピラゾリル尿素誘導体
|
|
ATE460402T1
(de)
*
|
2004-05-12 |
2010-03-15 |
Bristol Myers Squibb Co |
Für die behandlung von thrombotischen leiden geeignete harnstoffantagonisten des p2y1- rezeptors
|
|
US7550499B2
(en)
|
2004-05-12 |
2009-06-23 |
Bristol-Myers Squibb Company |
Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
WO2005113534A2
(en)
|
2004-05-12 |
2005-12-01 |
Schering Corporation |
Cxcr1 and cxcr2 chemokine antagonists
|
|
FR2872159B1
(fr)
*
|
2004-06-28 |
2007-10-05 |
Merck Sante Soc Par Actions Si |
Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
|
|
DE602005010714D1
(de)
|
2004-08-12 |
2008-12-11 |
Pfizer |
Der p38-map-kinase
|
|
EP1634573A1
(en)
*
|
2004-08-16 |
2006-03-15 |
The Procter and Gamble Company |
2-(Amino or substituted Amino)-5,6-substituted Phenol compounds, dyeing compositions containing them, and use thereof
|
|
CA2576170A1
(en)
*
|
2004-08-16 |
2006-03-02 |
The Procter & Gamble Company |
2-(amino or substituted amino)-5, 6-substituted phenol compounds, dyeing compositions containing them, and use thereof
|
|
WO2006043950A1
(en)
*
|
2004-10-20 |
2006-04-27 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
EP1814875A4
(en)
*
|
2004-10-20 |
2010-02-17 |
Univ California |
IMPROVED INHIBITORS OF SOLUBLE EPOXY HYDROLASE
|
|
JP2008517930A
(ja)
|
2004-10-21 |
2008-05-29 |
トランス テック ファーマ，インコーポレイテッド |
ＧａｌＲ１のアゴニストとしてのビススルホンアミド化合物、組成物、及び使用法
|
|
PE20061130A1
(es)
|
2004-11-19 |
2007-01-05 |
Arena Pharm Inc |
Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a
|
|
WO2006060762A2
(en)
*
|
2004-12-03 |
2006-06-08 |
Arena Pharmaceuticals, Inc. |
Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
AU2006206611A1
(en)
|
2005-01-19 |
2006-07-27 |
Bristol-Myers Squibb Company |
2-phenoxy-N- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as P2Y1 receptor inhibitors for the treatment of thromboembolic disorders
|
|
CN101160127A
(zh)
*
|
2005-01-19 |
2008-04-09 |
艾尼纳制药公司 |
用于预防或治疗进行性多灶性白质脑病而作为5-ht2a血清素受体调节剂的二芳基和芳基杂芳基脲衍生物
|
|
US20090305321A1
(en)
*
|
2005-03-23 |
2009-12-10 |
Astrazeneca Ab |
Assays for Allosteric Modulators of G-Protein Coupled Receptors (GPCRs)
|
|
US7714002B2
(en)
|
2005-06-27 |
2010-05-11 |
Bristol-Myers Squibb Company |
Carbocycle and heterocycle antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
DE602006020871D1
(de)
|
2005-06-27 |
2011-05-05 |
Bristol Myers Squibb Co |
Lineare harnstoffmimetika-antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden
|
|
US7728008B2
(en)
|
2005-06-27 |
2010-06-01 |
Bristol-Myers Squibb Company |
N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
WO2007002635A2
(en)
|
2005-06-27 |
2007-01-04 |
Bristol-Myers Squibb Company |
C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
|
|
GB0526255D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
CA2640090A1
(en)
*
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceuticals Corp. |
Substituted aromatic compounds for inflammation and immune-related uses
|
|
AU2007240365B2
(en)
*
|
2006-04-21 |
2011-12-15 |
Glaxosmithkline Llc |
IL-8 receptor antagonists
|
|
US8097626B2
(en)
*
|
2006-04-21 |
2012-01-17 |
Glaxosmithkline Llc |
IL-8 receptor antagonists
|
|
WO2007127930A2
(en)
*
|
2006-04-28 |
2007-11-08 |
Kansas State University Research Foundation |
Compounds affecting gap junction activity
|
|
EA016675B1
(ru)
|
2006-05-18 |
2012-06-29 |
Арена Фармасьютикалз, Инк. |
Способы получения фенилпиразолов и кристаллическая форма производного фенилпиразола
|
|
WO2007136680A2
(en)
|
2006-05-18 |
2007-11-29 |
Arena Pharmaceuticals, Inc. |
3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
USRE45336E1
(en)
|
2006-05-18 |
2015-01-13 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
|
CL2007001829A1
(es)
*
|
2006-06-23 |
2008-01-25 |
Smithkline Beecham Corp |
P-toluensulfonato de n-[4-cloro-2-hidroxi-3-(piperazina-1-sulfonil)fenil]-n-(2-cloro-3-fluorofenil)urea;procedimiento de preparacion;composicion farmaceutica;combinacion farmaceutica;y uso en el tratamiento de una enfermedad mediada por la quiimioquina il-8, tales como asma y epoc.
|
|
TWI415845B
(zh)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
|
|
US7960569B2
(en)
|
2006-10-17 |
2011-06-14 |
Bristol-Myers Squibb Company |
Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
WO2008047067A1
(en)
*
|
2006-10-20 |
2008-04-24 |
University Court Of The University Of Edinburgh |
Treatment of inflammatory disease
|
|
US9567327B2
(en)
|
2007-08-15 |
2017-02-14 |
Arena Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
|
MX2010003440A
(es)
*
|
2007-09-28 |
2010-04-21 |
Glaxosmithkline Llc |
Compuesto inhibidor de glicogeno fosforilasa y composicion farmaceutica del mismo.
|
|
US20110021538A1
(en)
*
|
2008-04-02 |
2011-01-27 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
|
TR201805216T4
(en)
|
2008-10-28 |
2018-06-21 |
Arena Pharm Inc |
COMPOSITIONS OF A USEFUL 5-HT2A SEROTONINE RECEPTOR MODULATOR FOR THE TREATMENT OF RELATED DISORDERS
|
|
WO2010092440A1
(en)
*
|
2009-02-16 |
2010-08-19 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Cxcr2 receptor antagonists for the treatment or the prevention of insulin resistance
|
|
US20120136033A1
(en)
*
|
2009-05-18 |
2012-05-31 |
President And Fellows Of Harvard College |
Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof
|
|
JP2013514313A
(ja)
*
|
2009-12-17 |
2013-04-25 |
ガルデルマ・リサーチ・アンド・デヴェロップメント |
皮膚障害の治療又は予防における化合物の使用
|
|
WO2011075596A1
(en)
|
2009-12-18 |
2011-06-23 |
Arena Pharmaceuticals, Inc. |
Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
BRPI1004176A2
(pt)
*
|
2010-10-25 |
2015-08-11 |
Univ Rio De Janeiro |
Compostos aril e/ou hetero aril uréias funcionalizados; processo de síntese desses composto; composição farmacêutica contendo tais compostos e usos
|
|
US8648118B2
(en)
|
2010-12-17 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
Bicyclic ring system substituted amide functionalised phenols as medicaments
|
|
EP2701699B1
(en)
|
2011-04-28 |
2019-10-16 |
The Broad Institute, Inc. |
Inhibitors of histone deacetylase
|
|
JP6337255B2
(ja)
|
2012-07-27 |
2018-06-06 |
ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. |
ヒストンデアセチラーゼの阻害剤
|
|
TWI516467B
(zh)
*
|
2012-11-21 |
2016-01-11 |
Nippon Soda Co |
A recording material using a non-phenolic compound is used
|
|
US9914717B2
(en)
|
2012-12-20 |
2018-03-13 |
The Broad Institute, Inc. |
Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
|
|
EP2957427B1
(en)
*
|
2013-02-13 |
2019-07-24 |
Oji Holdings Corporation |
Heat-sensitive recording body
|
|
CN105283316B
(zh)
*
|
2013-05-22 |
2018-03-30 |
王子控股株式会社 |
热敏记录体
|
|
HK1245660A1
(zh)
|
2015-06-12 |
2018-08-31 |
Axovant Sciences Gmbh |
有用於预防和治疗rem睡眠行为障碍的二芳基脲和芳基脲衍生物
|
|
EP3117835A1
(en)
*
|
2015-07-14 |
2017-01-18 |
Dompé farmaceutici s.p.a. |
Il-8 inhibitors for use in the treatment of certain urological disorders
|
|
WO2017011767A2
(en)
|
2015-07-15 |
2017-01-19 |
Axovant Sciences Ltd. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
|
|
US10093617B1
(en)
*
|
2015-10-30 |
2018-10-09 |
Sumitomo Chemical Company, Limited |
Method for producing 2-amino-4-substituted phenol
|
|
EP3476829B1
(en)
*
|
2016-06-22 |
2021-12-15 |
Fudan University |
Biaryl urea derivative or salt thereof, and manufacturing and application of same
|
|
CN107522641B
(zh)
*
|
2016-06-22 |
2020-05-05 |
复旦大学 |
联芳基脲类衍生物或其盐及其制备方法和用途
|
|
JP7252125B2
(ja)
*
|
2016-10-03 |
2023-04-04 |
ザ チルドレンズ メディカル センター コーポレーション |
糖尿病性腎症の予防および処置
|
|
JP2021510733A
(ja)
|
2018-01-12 |
2021-04-30 |
ケーディーエーシー セラピューティクス，インコーポレーテッドＫｄａｃ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
がんの処置のための選択的ヒストンデアセチラーゼ３（ｈｄａｃ３）インヒビターと免疫治療剤との組み合わせ
|
|
CN110698373A
(zh)
*
|
2019-11-07 |
2020-01-17 |
温州大学 |
N-（2-（甲硫基）苯基）乙酰胺类化合物的制备方法及其净化提纯方法
|
|
CN112321452B
(zh)
*
|
2020-09-11 |
2022-11-29 |
北京红惠新医药科技有限公司 |
厚朴酚衍生物、和厚朴酚衍生物及其盐酸盐、制备方法及应用
|
|
WO2025121190A1
(ja)
*
|
2023-12-08 |
2025-06-12 |
日産化学株式会社 |
重合体、樹脂組成物、液晶配向剤、樹脂被膜及び液晶配向膜
|
|
CN118063332A
(zh)
*
|
2024-02-29 |
2024-05-24 |
浙江鼎龙科技股份有限公司 |
一种2-羟基-4-乙基苯胺及其盐酸盐的制备方法
|